3D PRINTING, BIOPRINTING & STEM CELL TECH IN ARTICULAR CARTILAGE REGENERATION AND TREATING OSTEOSARCOMA
With
Associate Professor Claudia Di Bella
Orthopaedic surgeon, Melbourne, Australia &
Associate Professor of Surgery,
University of Melbourne, Australia &
Chair, Australian Orthopaedic Association (AOA) Research Foundation
RESEARCHER PROFILE
Filmed in Sydney, Australia | November 2026
Associate Professor Claudia Di Bella is an academic orthopaedic surgeon based in Melbourne, specialising in orthopaedic oncology and complex joint reconstruction. Originally trained at the world-renowned Rizzoli Orthopaedic Institute in Bologna, Italy, (IRCCS Istituto Ortopedico Rizzoli) she moved to Australia in 2010. She was awarded Fellowship of the Royal Australasian College of Surgeons in 2013 and Fellowship of Australian Orthopaedic Association (AOA) in 2014.
She is Associate Professor of Surgery at the University of Melbourne and leads a translational research program focused on tissue engineering and innovative solutions to improve outcomes for patients with musculoskeletal disease, in particular bone sarcomas. Her research has attracted over AUD $6 million in competitive funding, including an NHMRC–MRFF Clinical Investigator Grant, and has resulted in more than 60 peer-reviewed publications, book chapters and numerous national and international presentations. She is passionate about bridging the gap between scientific discovery and meaningful improvements in patient care.
As an Associate Professor of Surgery at the University of Melbourne, she is the clinical lead of the cartilage regeneration program and osteosarcoma 3D printing program at the Biofab3D, part of the Aikenhead Centre for Medical Discovery (ACMD).
Clinically, A/Prof Di Bella is one of Australia’s few orthopaedic oncology surgeons, managing complex bone and soft tissue tumours and performing high-volume limb salvage surgery and joint reconstruction. Her work combines surgical expertise, innovation and multidisciplinary care for patients facing life-changing diagnoses.
Beyond her clinical and academic roles, Claudia is a strong advocate for diversity, inclusion and representation in medicine. Through national and international leadership roles, including within orthopaedic surgery and sarcoma organisations, she actively mentors the next generation of surgeons and researchers, with a particular commitment to supporting women and underrepresented groups in STEMM and surgical careers.
Source: Supplied and supplemented
https://orcid.org/0000-0001-6871-1149
-
Paramedicine workforce across Australian & New Zealand
Liz Thyer is an Associate Professor in the Western Sydney University Paramedicine program and is passionate about innovations and excellence in health sciences teaching and learning.
She was an advanced life support paramedic with Ambulance Victoria for 11 years including roles as a clinical instructor and peer support officer. She has previously worked at Victoria University with the Paramedic programs and at Deakin University in Learning Futures.
-
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Large-scale clinical and population-based research
Christopher Reid is an internationally renowned cardiovascular epidemiologist with appointments as a Research Professor in both the School of Population Health at Curtin University and the School of Public Health and Preventive Medicine, at Monash University.
